How to mend a broken heart: Adult and induced pluripotent stem cell therapy for heart repair and regeneration

Drug Discovery Today

Volumn 20, Issue 6, 2015, Pages 667-685

  Wegener, Marie ^a   Bader, Augustinus ^a   Giri, Shibashish ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; CYCLIN A2; G PROTEIN COUPLED RECEPTOR KINASE 2; HISTONE DEACETYLASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; MICRORNA; RNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SOMATOMEDIN; SOMATOMEDIN 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT STEM CELL; BARTH SYNDROME; CARDIAC STEM CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CONGESTIVE CARDIOMYOPATHY; DRUG SCREENING; ELECTRIC ACTIVITY; EMBRYO DEVELOPMENT; EXOSOME; GENE TARGETING; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART REGENERATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOPLASTIC LEFT HEART SYNDROME; LEOPARD SYNDROME; LONG QT SYNDROME; MACROPHAGE; MITOCHONDRIAL TARGETING SIGNAL; MOLECULAR BIOLOGY; NONHUMAN; OXYGENATION; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TIMOTHY SYNDROME; TISSUE REGENERATION; ANIMAL; CELL LINEAGE; CONVALESCENCE; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASES; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DISEASES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIUM; PHENOTYPE; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION;

EID: 84935008946     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.02.010     Document Type: Review

References (124)

1. Maron, B. J. et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807-1816
2. Smits, J. et al. (2010) Considerations for patients awaiting heart transplantation. Thorac. Cardiovasc. Surg. 58, S179-S184
3. Stehlik, J. et al. (2011) The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report 2011. J. Heart Lung Transplant. 30, 1078-1094
4. Hoffman, F. M. (2005) Outcomes and complications after heart transplantation: a review. J. Cardiovasc. Nurs. 20, S31-S42
5. Aliabadi, A. et al. (2012) Current strategies and future trends in immunosuppression after heart transplantation. Curr. Opin. Organ Transplant. 17, 540-545
6. Stiefel, P. et al. (2013) Symptom experiences in patients after heart transplantation. J. Health Psychol. 18, 680-692
7. Løgstrup, S. and O'Kelly, S. (2012) ESC European Cardiovascular Disease Statistics 2012. European Heart Network
8. Sheng, C. et al. (2013) Current stem cell delivery methods for myocardial repair. Biomed. Res. Int. 2013, 1-15
9. Templin, C. et al. (2010) Stamm- und progenitorzellbasierte Therapieansätze. Herz 35, 445-457
10. Hare, J. M. and Chaparro, S. V. (2008) Cardiac regeneration and stem cell therapy. Curr. Opin. Organ Transplant. 13, 536-542
11. Murry, C. E. et al. (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation 112, 3174-3183
12. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
13. Nelson, T. J. et al. (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416
14. Li, X. et al. (2013) Intramyocardial injection of pig pluripotent stem cells improves left ventricular function and perfusion: a study in a porcine model of acute myocardial infarction. PLOS ONE 8, e66688
15. Gu, M. et al. (2012) Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ. Res. 111, 882-893
16. Zhang, Y. et al. (2011) Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS ONE 6, e19012
17. Halbach, M. et al. (2013) Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells. Cardiovasc. Res. 100, 432-440
18. Miki, K. et al. (2012) Bioengineeredmyocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl. Med. 1, 430-437
19. Zwi-Dantsis, L. et al. (2013) Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Eur. Heart J. 34, 1575-1586
20. Carpenter, L. et al. (2012) Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev. 21, 977-986
21. Chong, J. J. et al. (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277
22. Kawamura, M. et al. (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126(Suppl. 1), 29-37
23. Kawamura, M. et al. (2013) Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 128(Suppl. 1), 87-94
24. Pecha, S. et al. (2014) Human iPS-cell-derived engineered heart tissue for cardiac repair. Thorac. Cardiovasc. Surg 62, OP48
25. Barile, L. et al. (2007) Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 50, 31-48
26. Choi, S. H. et al. (2012) Perspectives on stem cell therapy for cardiac regeneration. Circ. J. 76, 1307-1312
27. Zhao, X. and Huang, L. (2013) Cardiac stem cells: a promising treatment option for heart failure. Exp. Ther. Med. 5, 379-383
28. Clifford, D. M. et al. (2012) Stem cell treatment for acute myocardial infarction. Cochrane Database Syst. Rev. 2, CD006536
29. Templin, C. et al. (2011) Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy current status and future developments. Int. J. Dev. Biol. 55, 407-417
30. Chugh, A. R. et al. (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126(Suppl. 1), S54-S64
31. Donndorf, P. et al. (2013) Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease. Curr. Pharm. Biotechnol. 14, 12-19
32. Zhang, J. et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41
33. Matsuura, K. et al. (2012) Creation of human cardiac cell sheets using pluripotent stem cells. Biochem. Biophys. Res. Commun. 425, 321-327
34. Christoforou, N. et al. (2013) Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLOS ONE 8, e65963
35. Wei, H. et al. (2012) One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res. 9, 87-100
36. Honda, M. et al. (2011) Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells. J. Pharmacol. Sci. 117, 149-159
37. Lee, Y.-K. et al. (2011) Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev. Rep. 7, 976-986
38. Gai, H. et al. (2009) Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol. Int. 33, 1184-1193
39. So, K. H. et al. (2011) Generation of functional cardiomyocytes from mouse induced pluripotent stem cells. Int. J. Cardiol. 153, 277-285
40. Germanguz, I. et al. (2011) Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J. Cell. Mol. Med. 15, 38-51
41. Kim, M. H. et al. (2012) In vitro monitoring of cardiomyogenic differentiation of mesenchymal stem cells using sodium iodide symporter gene. Tissue Eng. Regen. Med. 9, 304-310
42. Potdar, P. D. and Prasannan, P. (2013) Differentiation of human dermal mesenchymal stem cells into cardiomyocytes by treatment with 5-azacytidine: concept for regenerative therapy in myocardial infarction. ISRN Stem Cells 2013, 1-9
43. Xing, Y. et al. (2012) The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol. Cell. Biochem. 360, 279-287
44. Li, X. et al. (2007) Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell. Cardiol. 42, 295-303
45. Tokcaer-Keskin, Z. et al. (2009) Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies. Can. J. Physiol. Pharmacol. 87, 143-150
46. Carvalho, P. H. et al. (2013) Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes. Arq. Bras. Cardiol. 100, 82-89
47. Ge, X. et al. (2012) Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem Cells Dev. 21, 2798-2808
48. Choi, Y. S. et al. (2010) Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J. Cell. Mol. Med. 14, 878-889
49. Jumabay, M. et al. (2009) Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats. J. Mol. Cell. Cardiol. 47, 565-575
50. Dijk, A. et al. (2008) Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell Tissue Res. 334, 457-467
51. Li, T.-S. et al. (2008) TGF-β induces the differentiation of bone marrow stem cells into immature cardiomyocytes. Biochem. Biophys. Res. Commun. 366, 1074-1080
52. Labovsky, V. et al. (2010) Cardiomyogenic differentiation of human bone marrow mesenchymal cells: role of cardiac extract from neonatal rat cardiomyocytes. Differentiation 79, 93-101
53. Zhao, Z. et al. (2011) Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. J. Biomed. Sci. 18, 37
54. Zhu, Y. et al. (2009) ADSCs differentiated into cardiomyocytes in cardiac microenvironment. Mol. Cell. Biochem. 324, 117-129
55. Yan, X. et al. (2011) Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes. Mol. Cell. Biochem. 354, 21-28
56. Jin, M.-S. et al. (2010) Icariin-mediated differentiation of mouse adipose-derived stem cells into cardiomyocytes. Mol. Cell. Biochem. 344, 1-9
57. Kaichi, S. et al. (2010) Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc. Res. 88, 314-323
58. Uosaki, H. et al. (2012) Direct contact with endoderm-like cells efficiently induces cardiac progenitors from mouse and human pluripotent stem cells. PLOS ONE 7, e46413
59. Kuzmenkin, A. et al. (2009) Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 23, 4168-4180
60. Zwi, L. et al. (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523
61. Lian, X. et al. (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 109, E1848-E1857
62. Lin, B. et al. (2012) High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc. Res. 95, 327-335
63. Shinozawa, T. et al. (2012) Anovel purification methodofmurine embryonic stem celland human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation. J. Biomol. Screen. 17, 683-691
64. Oberwallner, B. et al. (2014) Human cardiac extracellular matrix supports myocardial lineage commitment of pluripotent stem cells. Eur. J. Cardiothorac. Surg. http://dx.doi.org/10.1093/ejcts/ezu163
65. Mauritz, C. et al. (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517
66. Chen, J. et al. (2013) mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation inpostnatal and adult hearts. Circ. Res. 112, 1557-1566
67. Brendan, P. et al. (2014) Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat. Mater. 13, 653-661
68. Mahmoud, A. I. et al. (2013) Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249-253
69. Wahlquist, C. et al. (2014) Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 508, 531-535
70. Shapiro, S. D. et al. (2014) Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci. Transl. Med. 6, 224ra27
71. Aurora, A. B. et al. (2014) Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 124, 1382-1392
72. Ibrahim, A. G.-E. et al. (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2, 606-619
73. Kim, H. et al. (2011) Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol. Cell 44, 532-544
74. Ferreira, R. et al. (2014) Lifelong exercise training modulates cardiac mitochondrial phosphoproteome in rats. J. Proteome Res. 13, 2045-2055
75. Thal, D. M. et al. (2012) Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem. Biol. 7, 1830-1839
76. Wang, Y. et al. (2014) Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J. Clin. Invest. 124, 2160-2167
77. Soh, J. et al. (2013) MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat. Med. 19, 892-900
78. Von Gise, A. et al. (2012) YAP 1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 109, 2394-2399
79. Rachmin, S. et al. (2014) Erbin is a negative modulator of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 111, 5902-5907
80. Furtado, M. B. et al. (2014) Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 114, 1422-1434
81. Courties, G. et al. (2013) In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J. Am. Coll. Cardiol. 63, 1556-1566
82. Puente, B. N. et al. (2014) The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157, 565-579
83. Behfar, A. et al. (2014) Cell therapy for cardiac repair: lessons from clinical trials. Nat. Rev. Cardiol. 11, 232-246
84. Inagawa, K. et al. (2012) Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ. Res. 111, 1147-1156
85. Qian, L. et al. (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598
86. Hou, P. et al. (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651-654
87. Senyo, S. E. et al. (2013) Mammalian heart renewalby pre-existing cardiomyocytes. Nature 493, 433-436
88. Russell, J. L. et al. (2012) Targeting native adult heart progenitors with cardiogenic small molecules. ACS Chem. Biol. 7, 1067-1076
89. Ott, H. C. et al. (2008) Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213-221
90. Lu, T. Y. et al. (2013) Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat. Commun. 4, 2307
91. Bolli, R. et al. (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847-1857
92. Ellison, G. M. et al. (2013) Adult Ckit+ cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154, 827-842
93. Zangi, L. et al. (2013) Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898-907
94. Zhang, R. et al. (2013) In vivo cardiac reprogramming contributes to zebrafish heart regeneration. Nature 498, 497-501
95. Shenje, L. T. et al. (2014) Precardiac deletion of Numb and Numblike reveals renewal of cardiac progenitors.eLife http://dx.doi.org/10.7554/eLife.02164
96. Anand, P. et al. (2013) BET bromodomains mediate transcriptional pause release in heart failure. Cell 154, 569-582
97. Heallen, T. et al. (2013) Hippo signaling impedes adult heart regeneration. Development 140, 4683-4690
98. Watson, C. J. et al. (2013) Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum. Mol. Genet. 23, 2176-2188
99. Huang, Y. et al. (2013) Igf signaling is required for cardiomyocyte proliferation during zebrafish heart development and regeneration. PLOS ONE http://dx.doi.org/10.1371/journal.pone.0067266
100. Choi, W. Y. et al. (2013) In vivo monitoring of cardiomyocyte proliferation to identify chemical modifiers of heart regeneration. Development 140, 660-666
101. Zhao, L. et al. (2014) Notch signaling regulates cardiomyocyte proliferation during zebrafish heart regeneration. Proc. Natl. Acad. Sci. U. S. A. 111, 1403-1408
102. Zhang, L. et al. (2012) Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. J. Biol. Chem. 287, 39338-39348
103. Xie, M. et al. (2014) Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129, 1139-1151
104. Kao, Y. H. et al. (2013) Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int. J. Cardiol. 168, 4178-4183
105. Aune, S. E. et al. (2014) Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. J. Mol. Cell. Cardiol. 72, 138-145
106. Moretti, A. et al. (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409
107. Egashira, T. et al. (2012) Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc. Res. 95, 419-429
108. Itzhaki, I. et al. (2012) Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human induced pluripotent stem cells. J. Am. Coll. Cardiol. 60, 990-1000
109. Matsa, E. et al. (2011) Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur. Heart J. 32, 952-962
110. Matsa, E. et al. (2013) Allele-specific RNA interference rescues the long-QT syndrome phenotype in human induced pluripotent stem cell cardiomyocytes. Eur. Heart J. 35, 1078-1087
111. Lahti, A. L. et al. (2012) Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis. Model. Mech. 5, 220-230
112. Davis, R. P. et al. (2012) Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125, 3079-3091
113. Yazawa, M. et al. (2011) Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234
114. Fatima, A. et al. (2011) In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell. Physiol. Biochem. 28, 579-592
115. Jung, C. B. et al. (2012) Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol. Med. 4, 180-191
116. Novak, A. et al. (2012) Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation. J. Cell. Mol. Med. 16, 468-482
117. Sun, N. et al. (2012) Patient specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 4, 130ra147
118. Lan, F. et al. (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12, 101-113
119. Carvajal-Vergara, X. et al. (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812
120. Ma, D. et al. (2013) Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 34, 1122-1133
121. Kim, C. et al. (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494, 105-110
122. Caspi, O. et al. (2013) Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ. Cardiovasc. Genet. 6, 557-568
123. Jiang, Y. et al. (2014) An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes. Stem Cells Transl. Med. 3, 416-423
124. Wang, G. et al. (2014) Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616-623